Janelidze, S., Stomrud, E., Smith, R., Palmqvist, S., Mattsson, N., Airey, D. C., . . . Hansson, O. (2020). Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease. Nat Commun.
Citação norma ChicagoJanelidze, Shorena, et al. "Cerebrospinal Fluid P-tau217 Performs Better Than P-tau181 As a Biomarker of Alzheimer’s Disease." Nat Commun 2020.
Citação norma MLAJanelidze, Shorena, et al. "Cerebrospinal Fluid P-tau217 Performs Better Than P-tau181 As a Biomarker of Alzheimer’s Disease." Nat Commun 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.